Standard Tuberculosis Treatment Regimen
Corresponding Organization : Qassim University
Variable analysis
- WHO standard 6-month regimen that included 2 months of isoniazid/rifampicin/pyrazinamide/ethambutol and 4 months of isoniazid/rifampicin (2HRZE/4HR)
- Directly observed therapy (DOT) strategy in the intensive phase of treatment
- Community volunteers involved in monitoring the patients in the continuous phase
- Relapse of the disease
- Chest X-ray performed when TB relapse was suspected
- Sputum acid-fast bacilli smear test conducted when TB relapse was suspected
- Independent variables not explicitly mentioned.
- Dependent variables not explicitly mentioned.
- Positive and negative controls not specified by authors.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!